Inibidor de recaptação de serotonina (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inibidor de recaptação de serotonina" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

9nih.gov

4^th place

8^th place

9doi.org

2^nd place

4^th place

1books.google.com

3^rd place

6^th place

1zenodo.org

621^st place

1,847^th place

1uspto.gov

1,459^th place

2,824^th place

1pat2pdf.org

low place

books.google.com

Gerald P. Koocher; John C. Norcross; Beverly A. Greene (2013). Psychologists' Desk Reference. [S.l.]: Oxford University Press. pp. 442–. ISBN 978-0-19-984550-7

doi.org

dx.doi.org

Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). «Pharmacological profile of antidepressants and related compounds at human monoamine transporters». Eur. J. Pharmacol. 340 (2–3): 249–58. PMID 9537821. doi:10.1016/s0014-2999(97)01393-9
Owens MJ, Knight DL, Nemeroff CB (2001). «Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine». Biol Psychiatry. 50 (5): 345-50. PMID 11543737. doi:10.1016/s0006-3223(01)01145-3
Deardorff WJ, Grossberg GT (2014). «A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine». Expert Opin Pharmacother. 15 (17): 2525–42. PMID 25224953. doi:10.1517/14656566.2014.960842
Gründer G, Hiemke C, Paulzen M, Veselinovic T, Vernaleken I (2011). «Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging». Pharmacopsychiatry. 44 (6): 236–48. PMID 21959785. doi:10.1055/s-0031-1286282
Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R (2009). «Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram». Int Clin Psychopharmacol. 24 (3): 119–25. PMID 19367152. doi:10.1097/YIC.0b013e32832a8ec8
Werling LL; Keller A; Frank JG; Nuwayhid SJ (2007). «A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder». Exp. Neurol. 207 (2): 248–57. PMID 17689532. doi:10.1016/j.expneurol.2007.06.013
Gillman PK (2005). «Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity». Br J Anaesth. 95 (4): 434–41. PMID 16051647. doi:10.1093/bja/aei210
Yeh SY; Dersch C; Rothman R; Cadet JL (setembro de 1999). «Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats». Synapse. 33 (3): 207–17. PMID 10420168. doi:10.1002/(SICI)1098-2396(19990901)33:3<207::AID-SYN5>3.0.CO;2-8
Li C, Shan L, Li X, Wei L, Li D (2014). «Mifepristone modulates serotonin transporter function». Neural Regen Res. 9 (6): 646–52. PMC 4146234. PMID 25206868. doi:10.4103/1673-5374.130112

nih.gov

ncbi.nlm.nih.gov

Tatsumi M, Groshan K, Blakely RD, Richelson E (1997). «Pharmacological profile of antidepressants and related compounds at human monoamine transporters». Eur. J. Pharmacol. 340 (2–3): 249–58. PMID 9537821. doi:10.1016/s0014-2999(97)01393-9
Owens MJ, Knight DL, Nemeroff CB (2001). «Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine». Biol Psychiatry. 50 (5): 345-50. PMID 11543737. doi:10.1016/s0006-3223(01)01145-3
Deardorff WJ, Grossberg GT (2014). «A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine». Expert Opin Pharmacother. 15 (17): 2525–42. PMID 25224953. doi:10.1517/14656566.2014.960842
Gründer G, Hiemke C, Paulzen M, Veselinovic T, Vernaleken I (2011). «Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging». Pharmacopsychiatry. 44 (6): 236–48. PMID 21959785. doi:10.1055/s-0031-1286282
Kasper S, Sacher J, Klein N, Mossaheb N, Attarbaschi-Steiner T, Lanzenberger R, Spindelegger C, Asenbaum S, Holik A, Dudczak R (2009). «Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram». Int Clin Psychopharmacol. 24 (3): 119–25. PMID 19367152. doi:10.1097/YIC.0b013e32832a8ec8
Werling LL; Keller A; Frank JG; Nuwayhid SJ (2007). «A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorder». Exp. Neurol. 207 (2): 248–57. PMID 17689532. doi:10.1016/j.expneurol.2007.06.013
Gillman PK (2005). «Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity». Br J Anaesth. 95 (4): 434–41. PMID 16051647. doi:10.1093/bja/aei210
Yeh SY; Dersch C; Rothman R; Cadet JL (setembro de 1999). «Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats». Synapse. 33 (3): 207–17. PMID 10420168. doi:10.1002/(SICI)1098-2396(19990901)33:3<207::AID-SYN5>3.0.CO;2-8
Li C, Shan L, Li X, Wei L, Li D (2014). «Mifepristone modulates serotonin transporter function». Neural Regen Res. 9 (6): 646–52. PMC 4146234. PMID 25206868. doi:10.4103/1673-5374.130112

pat2pdf.org

Pharmaceutical compositions containing mesembrine and related compounds. U.S. Patent 6,288,104 (PDF)

uspto.gov

patft.uspto.gov

Pharmaceutical compositions containing mesembrine and related compounds. U.S. Patent 6,288,104 (PDF)

zenodo.org

Yeh SY; Dersch C; Rothman R; Cadet JL (setembro de 1999). «Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats». Synapse. 33 (3): 207–17. PMID 10420168. doi:10.1002/(SICI)1098-2396(19990901)33:3<207::AID-SYN5>3.0.CO;2-8